Weight Loss Medications Reveal Hidden Cardiac Virtues The recent study from Anglia Ruskin University, published in Cardiovascular Diabetology Endocrinology Reports, sheds new light on the cardiovascular benefits of GLP 1 weight loss medications.
The research indicates that these drugs not only aid in weight management and blood sugar control but also significantly reduce the risk of heart attacks, strokes, and premature death.
The study's findings are based on a comprehensive review of data from over 90,000 participants in large international clinical trials assessing GLP 1 receptor agonists.